Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free
InVivo Therapeutics Holdings NASDAQ NVIV
$0.32 -0.17 -52.17%
Today share price
USA
Sector: Healthcare Industry: Health Care Equipment & Supplies
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 17 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

996.08K
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
-14.96M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.27
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
3.11M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-56.07 %
Upcoming events InVivo Therapeutics Holdings All events
No upcoming events scheduled
Overview Financials Key Metrics Dividends Industry overview Events

Stock chart InVivo Therapeutics Holdings

Stock analysis InVivo Therapeutics Holdings

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.11 53.32
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
0.06 17.34
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
1.61 38.59
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
1.71 0.82
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-100.73 18.14

Price change InVivo Therapeutics Holdings per year

0.50$ 2.00$
Min Max

Summary analysis InVivo Therapeutics Holdings

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure InVivo Therapeutics Holdings

Revenue and net income InVivo Therapeutics Holdings

All parameters
Stock news InVivo Therapeutics Holdings All news

About company InVivo Therapeutics Holdings

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). The company is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. InVivo Therapeutics Holdings Corp. was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.
Address:
One Kendall Square, Cambridge, MA, United States, 02139
Company name: InVivo Therapeutics Holdings
Issuer ticker: NVIV
ISIN: US46186M5067
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2010-10-29
Sector: Healthcare
Industry: Health Care Equipment & Supplies
Site: https://www.invivotherapeutics.com

On which stock exchange are InVivo Therapeutics Holdings (NVIV) stocks traded?

InVivo Therapeutics Holdings (NVIV) stocks are traded on NASDAQ.

What is the ticker of InVivo Therapeutics Holdings stocks (NVIV)?

The stock ticker of InVivo Therapeutics Holdings’s stocks or in other words, the code is NVIV. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does InVivo Therapeutics Holdings (NVIV) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, InVivo Therapeutics Holdings (NVIV) belongs to the «Healthcare» sector and the «Health Care Equipment & Supplies» industry.

In what currency are InVivo Therapeutics Holdings (NVIV) stocks traded?

InVivo Therapeutics Holdings (NVIV) stocks are traded on the NASDAQ exchange in dollars.

What is the price of InVivo Therapeutics Holdings (NVIV) stocks today?

The current price of InVivo Therapeutics Holdings stocks on 28.04.2024 is 0.3207 dollars. per share.

What is the dynamics of InVivo Therapeutics Holdings (NVIV) stocks from the beginning of the year?

InVivo Therapeutics Holdings (NVIV) quotes have increased by -59.38% from the beginning of the year up to 0.3207 dollars. per 1 stocks.

How much did InVivo Therapeutics Holdings (NVIV) stocks increase in апреле 2024?

This month InVivo Therapeutics Holdings (NVIV) quotes have increased by 0% to 0.3207 dollars. per share.

How much are InVivo Therapeutics Holdings (NVIV) stocks worth?

Today, on October, 28.04.2024 InVivo Therapeutics Holdings’s (NVIV) stocks cost 0.3207 dollars..

What is the market capitalization of InVivo Therapeutics Holdings (NVIV)?

Capitalization is the market value of InVivo Therapeutics Holdings (NVIV) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 28.04.2024, the market capitalization of InVivo Therapeutics Holdings (NVIV) is estimated at about 996080 dollars.